课题基金 / 基金详情

Analysis of the mechanism for coupled translation in cellular and virus mRNAs

Analysis of the mechanism for coupled translation in cellular and virus mRNAs
细胞和病毒 mRNA 耦合翻译机制分析
批准号:
BB/I022880/1
负责人:
Andrew Easton
金额:
$58.05万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --

项目摘要

项目成果

Andrew Easton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Translation is the final stage of the most fundamental process in biology in which the genetic material of the organism is turned into proteins. During the process of translation; ribosomes (which are the cellular machines that build proteins) make the new protein by following a plan written in a molecule called mRNA. mRNA is a single stranded molecule made up from 4 different components (called nucleotides) which act like letters in our alphabet to make a code. Scientists have been studying the way the ribosome machine works in eukaryotes (higher organisms) for many years and thought that all proteins are made in the same way. Viruses are a group of microscopic organisms which infect and cause diseases in organisms. During the infection process they must use the infected cell's apparatus including ribosomes to make more new viruses. Viruses have been forced to exploit all of the cell systems to survive and multiply faster before the infected cell can destroy it. Importantly, all strategies used by the virus must be compatible with the workings of the cell to function. Interestingly, by studying these new strategies Scientists have seen that not only, do the viruses use them, but the cells also do. We are studying a virus called respiratory syncytial virus (RSV) which will have likely infected most individuals a child and will have a good chance of infected them again as adults. The RSV virus also uses a novel mechanism to express a protein called M2-2. Here instead of just making one protein from a piece of mRNA two proteins are made. We are interested in working out how this is possible. We have shown that in order to make the second protein: M2-2 the first protein M2-1 must be made. This means the ribosomes must go in reverse as the coding sequence for the second protein overlaps with the coding sequence of the first. This was an important finding as ribosomes had not previously been shown to have this ability. Important regions within this mRNA have been discovered that allow the second protein to be made. These regions appear to be present throughout the coding sequence of M2-1. If we change these regions by introducing mutations or make deletions the amounts of the second protein made are reduced, in some cases completely, indicating their importance. These sections contain a lot of secondary structure. Secondary structure occurs where the nucleotides in different parts of the mRNA molecule can interact together, which can be thought of as like fitting two pieces of a jig-saw together. As more pieces are added the structure gets stronger. We are going to use the latest techniques to capture and pinpoint where the ribosome is on the M2-1 RNA. If the ribosome is in one location more than by random chance this will indicate the location where the ribosome has paused. This could 1) allow the ribosome to effectively think and change its mind. So instead of doing what it should and following a signal to stop and move away it re-starts and makes a new protein and or 2) The secondary structures inhibit ribosome movements so that gaps appear on the mRNA molecule so a ribosome stopping can also move back and not be blocked. We are also interested in finding out if other proteins assist in this process. We aim to fish out these proteins using our M2-1 RNA as bait. We have also discovered for the first time that our genome contains examples of mRNA that carry out this process. We have at least 5 examples to investigate further and highlights the universal use of this mechanism.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1261/rna.041574.113
发表时间: 2014-03
期刊: RNA (New York, N.Y.)
影响因子: --
作者: [Gould PS, Dyer NP, Croft W, Ott S, Easton AJ]
通讯作者: Easton AJ
FLIP - Commercial development of antivirals for bovine respiratory syncytial virus
  • 批准号:
    BB/M006263/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $2.66万
  • 财政年份:
    2014
  • 负责人:
    Andrew Easton
  • 依托单位:
Novel Inhibitors of Bovine Respiratory Syncytial Virus
  • 批准号:
    BB/M005534/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $1.02万
  • 财政年份:
    2014
  • 负责人:
    Andrew Easton
  • 依托单位:
Small molecule inhibitors for bovine respiratory syncytial virus
  • 批准号:
    BB/L024438/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $24.81万
  • 财政年份:
    2014
  • 负责人:
    Andrew Easton
  • 依托单位:
Coupled translation: a novel process for translation of two overlapping open reading frames in mRNA
  • 批准号:
    BB/F007612/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $44.9万
  • 财政年份:
    2008
  • 负责人:
    Andrew Easton
  • 依托单位:
国内基金
海外基金
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
  • 批准号:
    82371332
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    胡琴
  • 依托单位: